EDN1 and endothelial dysfunction: We also observed increased expression of the potent vasoactive peptide endothelin-1 (EDN1) as well as oxidized low-density lipoprotein receptor-1 (OLR1), which is a key molecule associated with endothelial dysfunction during atherosclerosis progression.